Abiomed says a quartet of private health insurers expanded their reimbursement policies for its flagship Impella heart pump.
Abiomed (NSDQ:ABMD) won expanded reimbursement for its flagship Impella heart pump from 4 private and Medicare Advantage insurers, including 1 of the largest names in the industry.
Humana, UnitedHealthcare Medicare Risk, Independence Blue Cross and Capital Blue Cross. The expanded coverage at the private or Medicare Advantage plans includes new Impella policies.
“This is huge for us. Humana is 1 of the largest commercial payers in the country, and for Humana to update these coverage policies to include Impella opens up a whole new patient population for us,” Aimee Genzler, communications manager at Abiomed, told MassDevice.com today in a phone interview.
